Ralstonia pickettii -: innocent bystander or a potential threat?

被引:65
作者
Stelzmueller, I
Biebl, M
Wiesmayr, S
Eller, M
Hoeller, E
Fille, M
Weiss, G
Lass-Floerl, C
Bonatti, H
机构
[1] Innsbruck Med Univ, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Paediat, A-6020 Innsbruck, Austria
[3] Innsbruck Med Univ, Dept Hyg Microbiol & Social Med, A-6020 Innsbruck, Austria
[4] Innsbruck Med Univ, Dept Gen Internal Med Clin Immunol & Infect Dis, A-6020 Innsbruck, Austria
关键词
antimicrobial susceptibility; cystic fibrosis patients; immunocompromised patients; infections; Ralstonia pickettii; resistance;
D O I
10.1111/j.1469-0691.2005.01309.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Ralstonia pickettii can be isolated from water, soil and plants, and can also form part of the commensal flora of the oral cavity and the upper respiratory tract of healthy individuals. R. pickettii is an infrequent pathogen, but can cause infections, mainly of the respiratory tract, in immunocompromised and cystic fibrosis patients. It can be isolated from a variety of clinical specimens, including sputum, blood, wound infections, urine, ear and nose swabs, and cerebrospinal fluid. Resistance can occur to ciprofloxacin, trimethoprim-sulphamethoxazole, piperacillin-tazobactam, imipenem-cilastatin and ceftazidime. Early detection of R. pickettii allows prompt appropriate antimicrobial therapy with a favourable outcome, but removal of infected indwelling devices is mandatory.
引用
收藏
页码:99 / 101
页数:3
相关论文
共 20 条
[1]   FACTORS ASSOCIATED WITH PSEUDOMONAS-PICKETTII INTRINSIC CONTAMINATION OF COMMERCIAL RESPIRATORY THERAPY SOLUTIONS MARKETED AS STERILE [J].
ANDERSON, RL ;
BLAND, LA ;
FAVERO, MS ;
MCNEIL, MM ;
DAVIS, BJ ;
MACKEL, DC ;
GRAVELLE, CR .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1985, 50 (06) :1343-1348
[2]   Ralstonia pickettii traced in blood culture bottles [J].
Boutros, M ;
Gonullu, N ;
Casetta, A ;
Guibert, M ;
Ingrand, D ;
Lebrun, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (07) :2666-2667
[3]   Infection by Ralstonia species in cystic fibrosis patients:: Identification of R-pickettii and R-mannitolilytica by polymerase chain reaction [J].
Coenye, T ;
Vandamme, P ;
LiPuma, JJ .
EMERGING INFECTIOUS DISEASES, 2002, 8 (07) :692-696
[4]   Characterization of clinically isolated Ralstonia mannitolilytica strains using random amplification of polymorphic DNA (RAPD) typing and antimicrobial sensitivity, and comparison of the classification efficacy of phenotypic and genotypic assays [J].
Daxboeck, F ;
Stadler, M ;
Assadian, O ;
Marko, E ;
Hirschl, AM ;
Koller, W .
JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (01) :55-61
[5]   Nosocomial outbreak of Burkholderia pickettii infection due to a manufactured intravenous product used in three hospitals [J].
Fernandez, C ;
Wilhelmi, I ;
Andradas, E ;
Gaspar, C ;
Gomez, J ;
Romero, J ;
Mariano, JA ;
Corral, O ;
Rubio, N ;
Elviro, J ;
Fereres, J .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) :1092-1095
[6]   OXA-60, a chromosomal, inducible, and imipenem-hydrolyzing class D β-lactamase from Ralstonia pickettii [J].
Girlich, D ;
Naas, T ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) :4217-4225
[7]   Outbreak of Pseudomonas fluorescens bacteremia among oncology patients [J].
Hsueh, PR ;
Teng, LJ ;
Pan, HJ ;
Chen, YC ;
Sun, CC ;
Ho, SW ;
Luh, KT .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2914-2917
[8]   Ralstonia pickettii outbreak associated with contaminated distilled water used for respiratory care in a paediatric intensive care unit [J].
Kendirli, T ;
Çiftci, E ;
Ince, E ;
Incesoy, S ;
Güriz, H ;
Aysev, AD ;
Tutar, E ;
Yavuz, G ;
Dogru, Ü .
JOURNAL OF HOSPITAL INFECTION, 2004, 56 (01) :77-78
[9]   Two cases of Ralstonia pickettii bacteremias in a pediatric oncology unit requiring removal of the Port-A-Caths [J].
Kismet, E ;
Atay, AA ;
Demirkaya, E ;
Aydin, HI ;
Aydogan, H ;
Koseoglu, V ;
Gokcay, E .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (01) :37-38
[10]   A multistate nosocomial outbreak of Ralstonia pickettii colonization associated with an intrinsically contaminated respiratory care solution [J].
Labarca, JA ;
Trick, WE ;
Peterson, CL ;
Carson, LA ;
Holt, SC ;
Arduino, MJ ;
Meylan, M ;
Mascola, L ;
Jarvis, WR .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1281-1286